(Q33768758)

English

Gatifloxacin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

Gatifloxacin (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

C M Perry

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J A Barman Balfour

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

H M Lamb

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

58

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

683-96; discussion 697-8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

https://scigraph.springernature.com/pub.10.2165/00003495-199958040-00010

0 references

In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in-vitro and in-vivo activity of AM-1155 against anaerobic bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in vitro activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia species isolates including evaluation of disk diffusion and E test methods.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro and in-vivo activity of a new quinolone AM-1155 against Mycoplasma pneumoniae

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expanded activity and utility of the new fluoroquinolones: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial activity of gatifloxacin tested against Neisseria gonorrhoeae using three methods and a collection of fluoroquinolone-resistant strains

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance Program

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Grou

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of 6-fluoro-8-methoxy quinolone (AM-1155) against chronic airway infection with Pseudomonas aeruginosa in a rat model

1 reference

https://pubmed.ncbi.nlm.nih.gov/10551438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199958040-00010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33768758&oldid=1606563597"